Takenori Shimo
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Optimization of 2',4'-BNA/LNA-Based Oligonucleotides for Splicing Modulation in Vitro.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Effect of chemical modification on the exon-skipping activity of heteroduplex oligonucleotides.
Journal: Molecular therapy. Nucleic acids
Published: March 06, 2024
Design and evaluation of antisense sequence length for modified mouse U7 small nuclear RNA to induce efficient pre-messenger RNA splicing modulation in vitro.
Journal: PloS one
Published: December 28, 2023
Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids.
Journal: International journal of molecular sciences
Published: February 15, 2021
Enhancement of exon skipping activity by reduction in the secondary structure content of LNA-based splice-switching oligonucleotides.
Journal: Chemical communications (Cambridge, England)
Published: May 25, 2019
Optimization of 2',4'-BNA/LNA-Based Oligonucleotides for Splicing Modulation In Vitro.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2018
Construction of a tri-chromatic reporter cell line for the rapid and simple screening of splice-switching oligonucleotides targeting DMD exon 51 using high content screening.
Journal: PloS one
Published: December 19, 2017
Designing Effective Antisense Oligonucleotides for Exon Skipping.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 26, 2017
A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping.
Journal: Journal of human genetics
Published: July 28, 2017
Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.
Journal: Nucleic acids research
Published: June 18, 2014
Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein.
Journal: Transplantation proceedings
Published: May 09, 2012
Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-α production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo.
Journal: Clinical and experimental immunology
Published: October 12, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026